Document Detail


Redox Protein Expression Predicts Radiotherapeutic Response in Early-Stage Invasive Breast Cancer Patients.
MedLine Citation:
PMID:  21300479     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Early-stage invasive breast cancer patients have commonly undergone breast-conserving surgery and radiotherapy. In a large majority of these patients, the treatment is effective; however, a proportion will develop local recurrence. Deregulated redox systems provide cancer cells protection from increased oxidative stress, such as that induced by ionizing radiation. Therefore, the expression of redox proteins was examined in tumor specimens from this defined cohort to determine whether such expression could predict response. METHODS AND MATERIALS: The nuclear and cytoplasmic expression of nine redox proteins (glutathione, glutathione reductase, glutaredoxin, glutathione peroxidase 1, 3, and 4, and glutathione S-transferase-θ, -π, and -α) was assessed using conventional immunohistochemistry on a tissue microarray of 224 tumors. RESULTS: A high cytoplasmic expression of glutathione S-transferase-θ significantly correlated with a greater risk of local recurrence (p = .008) and, when combined with a low nuclear expression (p = .009), became an independent predictive factor (p = .002) for local recurrence. High cytoplasmic expression of glutathione S-transferase-θ also correlated with a worse overall survival (p = .009). Low nuclear and cytoplasmic expression of glutathione peroxidase 3 (p = .002) correlated with a greater risk of local recurrence and was an independent predictive factor (p = .005). These proteins did not correlate with tumor grade, suggesting their function might be specific to the regulation of oxidative stress rather than alterations of tumor phenotype. Only nuclear (p = .005) and cytoplasmic (p = .001) expression of glutathione peroxidase 4 correlated with the tumor grade. CONCLUSIONS: Our results support the use of redox protein expression, namely glutathione S-transferase-θ and glutathione peroxidase 3, to predict the response to radiotherapy in early-stage breast cancer patients. If incorporated into routine diagnostic tests, they have the potential to aid clinicians in their stratification of patients into more tailored treatment regimens. Future targeted therapies to these systems might improve the efficacy of reactive oxygen species-inducing therapies, such as radiotherapy.
Authors:
Caroline M Woolston; Ahmad Al-Attar; Sarah J Storr; Ian O Ellis; David A L Morgan; Stewart G Martin
Related Documents :
8860069 - Improved survival in the danish center-treated cystic fibrosis patients: results of agg...
2313329 - Why are local recurrences after breast-conserving therapy more frequent in younger pati...
10464699 - Prognosis of patients with stage iiib-iva squamous cell carcinoma of the cervix followi...
6939189 - Malignant tumours of the colon and rectum in patients aged 30 and younger.
21050439 - Is standard breast-conserving therapy (bct) in elderly breast cancer patients justified...
20018399 - Investigation and management of lung cancer in older adults.
25268369 - The impact of low-grade toxicity in older people with cancer undergoing chemotherapy.
8422639 - Hodgkin disease, nodular sclerosis type. implications of histologic subclassification.
24388339 - Histological differentiation predicts post-liver transplantation survival time.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-5
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  -     ISSN:  1879-355X     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Division of Clinical Oncology, University of Nottingham School of Molecular Medical Sciences, Nottingham, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting Pelvic Lymph Node Involvement in Current-Era Prostate Cancer.
Next Document:  Dynamic MRI Analysis of Tumor and Organ Motion during Rest and Deglutition and Margin Assessment for...